Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation

References

• BarnesPJIntroduction: how can we improve asthma management?Curr Med Res Opin200521Suppl 4S1S3
   PubMed Web of Science ®Google Scholar
• CrossSAsthma inhalation delivery systems: the patient’s viewpointJ Aerosol Med200114Suppl 1S3S711424891
   PubMedGoogle Scholar
• MagnussenHNovolizer: how does it fit into inhalation therapy?Curr Med Res Opin200521Suppl 4S39S46 discussion S4716138944
   PubMed Web of Science ®Google Scholar
• MelaniASInhalatory therapy training: a priority challenge for the physicianActa Biomed200778323324518330086
   PubMedGoogle Scholar
• Dal NegroRWPoveroMAcceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patientsMultidiscip Respir Med201511726865979
   PubMed Web of Science ®Google Scholar
• VirchowJCGuidelines versus clinical practice-which therapy and which device?Respir Med200498Suppl BS28S3415481286
   PubMed Web of Science ®Google Scholar
• RestrepoRDAlvarezMTWittnebelLDMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis20083337138418990964
   PubMedGoogle Scholar
• LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med2008102459360418083019
   PubMed Web of Science ®Google Scholar
• SouzaMLMeneghiniACFerrazEViannaEOBorgesMCKnowledge of and technique for using inhalation devices among asthma patients and COPD patientsJ Bras Pneumol2009359824831 Portuguese19820807
   PubMed Web of Science ®Google Scholar
• RaherisonCGirodetPOEpidemiology of COPDEur Respir Rev20091811421322120956146
   PubMedGoogle Scholar
• ChrystynHSmallMMilliganGHigginsVGilEGEstruchJImpact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPDRespir Med2014108235836524209768
   PubMed Web of Science ®Google Scholar
• LareauSCYawnBPImproving adherence with inhaler therapy in COPDInt J Chron Obstruct Pulmon Dis2010540140621191434
   PubMedGoogle Scholar
• HodderRPriceDPatient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerInt J Chron Obstruct Pulmon Dis2009438139019888356
   PubMedGoogle Scholar
• van der PalenJGinkoTKrokerAPreference, satisfaction and errors with two dry powder inhalers in patients with COPDExpert Opin Drug Deliv20131081023103123745954
   PubMed Web of Science ®Google Scholar
• ChrystynHNiederlaenderCThe Genuair® inhaler: a novel, multidose dry powder inhalerInt J Clin Pract201266330931722340451
   PubMed Web of Science ®Google Scholar
• MagnussenHWatzHZimmermannIPeak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPDRespir Med2009103121832183719651504
   PubMed Web of Science ®Google Scholar
• KomaseYAsakoAKobayashiASharmaREase-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or olderInt J Chron Obstruct Pulmon Dis201491365137525525354
   PubMed Web of Science ®Google Scholar
• KozmaCMSlatonTLMonzBUHodderRReesePRDevelopment and validation of a patient satisfaction and preference questionnaire for inhalation devicesTreat Respir Med200541415215725049
   PubMedGoogle Scholar
• SharpeDYour chi-square test is statistically significant: now what?Pract Assess Res Eval2015208110
   Google Scholar
• AgrestiAAn Introduction to Categorical Data AnalysisHoboken, New Jersey, USAWiley2007
   Google Scholar
• GuyattGHOsobaDWuAWWyrwichKWNormanGRClinical Significance Consensus Meeting GroupMethods to explain the clinical significance of health status measuresMayo Clin Proc200277437138311936935
   PubMed Web of Science ®Google Scholar
• MenezesAMPerez-PadillaRJardimJRPLATINO TeamChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
   PubMed Web of Science ®Google Scholar
• Global Strategy for Diagnosis, Management, and Prevention of COPD — 2016Global Initiative for Chronic Obstructive Lung Disease – GOLD Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed May 26, 2017
   Google Scholar
• MontoyaAPriceBHMenearMLepageMBrain imaging and cognitive dysfunctions in Huntington’s diseaseJ Psychiatry Neurosci2006311212916496032
   PubMed Web of Science ®Google Scholar
• SunderlandABowersMPSlumanSMWilcockDJArdronMEImpaired dexterity of the ipsilateral hand after stroke and the relationship to cognitive deficitStroke199930594995510229726
   PubMed Web of Science ®Google Scholar
• ParkDCReuter-LorenzPThe adaptive brain: aging and neurocognitive scaffoldingAnnu Rev Psychol20096017319619035823
   PubMed Web of Science ®Google Scholar
• SeidlerRDBernardJABurutoluTBMotor control and aging: links to age-related brain structural, functional, and biochemical effectsNeurosci Biobehav Rev201034572173319850077
   PubMed Web of Science ®Google Scholar
• BlasiFCanonicaGWCentanniSGenuair® usability test: results of a national public survey of the elderlyCOPD201613336737126645660
   PubMedGoogle Scholar
• RajanSKGogtayJAEase-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian populationLung India201431436637425378845
   PubMedGoogle Scholar
• PascualSFeimerJDe SoyzaAPreference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre studyNPJ Prim Care Respir Med2015251501825927321
   PubMed Web of Science ®Google Scholar
• SvedsaterHDalePGarrillKWalkerRWoepseMWQualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPDBMC Pulm Med2013137224314123
   PubMed Web of Science ®Google Scholar